Sidra Medicine Empowers Rare Disease Research QF Entity opens accessibility to state-of-the-art research services 28 February 2024, Doha, Qatar – In support of Rare Disease Day, Sidra Medicine today announced the accessibility of its unique an… Continue Reading.....

Sidra Medicine and Msheireb Museums Launch Science Café Series QF Entities to bring science to the community 26 February 2024, Doha, Qatar – Sidra Medicine and Msheireb Museums, members of Qatar Foundation, are launching their first Science Café series. The… Continue Reading.....

Sidra Medicine Expands ENT Services QF Entity performs first pediatric vocal cord injection medialization procedure   06 February 2024, Doha, Qatar –Sidra Medicine, a member of Qatar Foundation, has expanded its pediatric Oto… Continue Reading.....

Sidra Medicine Pioneers New Pediatric Treatment Protocol for Infant with Congenital Hyperinsulinism 28 January 2024, Doha, Qatar – In a world first, Sidra Medicine, a member of Qatar Foundation, has pioneered a new treatment protocol for a young infant with congenital hyperinsulinism. The findings h… Continue Reading.....

Sidra Medicine Study Reveals Impact of Highly Processed Foods on Brain Metabolism and Sense of Smell 24 January 2024, Doha, Qatar – Researchers at Sidra Medicine, a member of Qatar Foundation, in collaboration with teams from the Universidade Federal do Rio Grande do Sul (Brazil) and Monell Chemical … Continue Reading.....

Sidra Medicine Study Recognized as Key Advancement in Cancer Microbiome Field 21 January 2024, Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, is proud to announce that one of its research studies published in Nature Medicine in May 2023, has been featured in the Ye… Continue Reading.....